Your session is about to expire
← Back to Search
Behavioural Intervention
SweetDreams for Autism Spectrum Disorder
N/A
Waitlist Available
Led By Lauren Asarnow, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to end of treatment (anticipated average exposure 1 month)
Awards & highlights
Summary
This trial will test an online program called SweetDreams that helps preschool-aged children with Autism Spectrum Disorder (ASD) sleep better. The program provides videos and educational materials for parents, making it easier for them to get help. It can be accessed on computers, tablets, and phones.
Eligible Conditions
- Autism Spectrum Disorder
- Autism
- Insomnia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to end of treatment (anticipated average exposure 1 month)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to end of treatment (anticipated average exposure 1 month)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Children's Sleep Habits Questionnaire (CSHQ)
Secondary outcome measures
Change in Pittsburgh Sleep Quality Index (PSQI)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SweetDreamsExperimental Treatment1 Intervention
Access to a mobile and computer accessible adaptation of existing evidence based sleep interventions.
Group II: Waitlist ControlActive Control1 Intervention
Wait list condition with future access to a mobile and computer accessible adaptation of existing evidence based sleep interventions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SweetDreams
2020
N/A
~20
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,528 Previous Clinical Trials
15,242,612 Total Patients Enrolled
6 Trials studying Autism Spectrum Disorder
237 Patients Enrolled for Autism Spectrum Disorder
Lauren Asarnow, PhDPrincipal InvestigatorUniversity of California, San Francisco
2 Previous Clinical Trials
112 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger